<DOC>
	<DOCNO>NCT00502086</DOCNO>
	<brief_summary>The purpose study evaluate whether Viusid , nutritional supplement , reduce mortality complication ( ascites , spontaneous bacterial peritonitis , hepatorenal syndrome , hepatic encephalopathy , gastrointestinal bleeding , sepsis hepatocellular carcinoma ) patient cirrhosis liver secondary HCV infection comparison placebo , 96 week treatment .</brief_summary>
	<brief_title>Efficacy Safety Viusid Patients With Hepatic Cirrhosis Secondary Hepatitis C Virus Infection .</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<criteria>Histological clinical diagnosis cirrhosis . HCV infection confirm positive test antiHCV antibody HCV RNA detectable serum Polymerase Chain Reaction . Patients nonresponders previous treatment pegylated interferon ribavirin naïve patient decompensated cirrhosis ( ChildPugh score ≥ 7 ) contraindicate antiviral treatment . Presence compensate decompensated ( Stage A , B C accord ChildPugh Classification ) . Absence clinical ultrasonographic evidence liver cancer , αfetoprotein level ≤ 200 ng/ml . Age le 18 great 70 year . Presence uncontrollable clinical biochemical complication relate severe liver failure ( hepatic encephalopathy , hepatorenal syndrome , gastrointestinal bleeding , serum bilirubin level great 5 mg/dL , international normalize ratio great 2.5 ) . Active alcoholism . Serum creatinine great 2 mg/dL . Hepatocellular carcinoma . Refusal participate study . Concomitant disease reduce life expectancy . Severe psychiatric condition . Coinfection hepatitis A B HIV . Drug dependence . Pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Chronic hepatitis C</keyword>
	<keyword>Cirrhosis liver</keyword>
	<keyword>Mortality</keyword>
	<keyword>Complications</keyword>
	<keyword>Health-related quality live</keyword>
	<keyword>Hepatocellular carcinoma</keyword>
	<keyword>Nutritional supplement</keyword>
</DOC>